Human breast cancer stem cells and sex hormones-A narrative review

Menopause

Volumn 17, Issue 4, 2010, Pages 801-810

  Eden, John A ^a,b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b ROYAL HOSPITAL FOR WOMEN   (Australia)

Author keywords

Breast cancer stem cells; Breast development; Estrogen; Human breast stem cells; Progesterone; Progestin

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; GESTAGEN; HERMES ANTIGEN; PROGESTERONE; PROGESTERONE RECEPTOR; SEX HORMONE; TRASTUZUMAB; SIGNAL PEPTIDE;

ADIPOCYTE; ANGIOGENESIS; BREAST CANCER; BREAST CARCINOGENESIS; BREAST DEVELOPMENT; BREAST METASTASIS; CANCER RISK; CANCER STEM CELL; FIBROBLAST; HORMONAL THERAPY; HUMAN; INFLAMMATORY CELL; INTRADUCTAL CARCINOMA; LONG TERM CARE; MENOPAUSE; NONHUMAN; PATHOPHYSIOLOGY; PREGNANCY; REVIEW; BREAST; BREAST TUMOR; CYTOLOGY; FEMALE; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHYSIOLOGY; PUBERTY; STEM CELL;

BREAST; BREAST NEOPLASMS; ESTROGENS; FEMALE; FIBROBLASTS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MENOPAUSE; NEOPLASTIC STEM CELLS; NEOVASCULARIZATION, PATHOLOGIC; PREGNANCY; PROGESTERONE; PROGESTINS; PUBERTY; STEM CELLS;

EID: 77954957349     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/gme.0b013e3181d3cdd7     Document Type: Review

References (75)

1. Trichopoulos D, Adami HO, Ekbom A, et al. Early life events and conditions and breast cancer risk: from epidemiology to etiology. Int J Cancer 2008;122:481-485.
2. Nowell PC. The clonal evolution of tumor cell populations. Science 1976;194:23-28.
3. Russo J, Russo IH. Development of the human breast. Maturitas 2004;49:2-15.
4. Baik I, Becker PS, DeVito WJ, et al. Stem cells and prenatal origin of breast cancer. Cancer Causes Control 2004;15:517-530.
5. Kalirai H, Clarke RB. Human breast epithelial stem cells and their regulation. J Pathol 2006;208:7-16.
6. Kordon EC, Smith GH. An entire functional mammary gland may comprise the progeny from a single cell. Development 1998;125: 1921-1930.
7. Villadsen R, Fridriksdottir AJ, Ronnov-Jessen L, et al. Evidence for a stem cell hierarchy in the adult human breast. J Cell Biol 2007;177:87-101.
8. Al-Hajj M, Wicha MS, Benito-Hernandez A, et al. Prospective iden-tification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003;100:3983-3988. (Pubitemid 36418143)
9. Dontu G, El-Ashry D, Wicha M. Breast cancer, stem/progenitor cells and the estrogen receptor. Trends Endocrinol Metab 2004;15: 193-197. (Pubitemid 38833988)
10. Ponti D, Zaffaroni N, Capelli C, Daidone MG. Breast cancer stem cells: an overview. Eur J Cancer 2006;42:1219-1224.
11. Dalerba P, Cho RW, Clarke M. Cancer stem cells: models and concepts. Annu Rev Med 2007;58:267-284. (Pubitemid 46706514)
12. Ginestier C, Hur MH, Charafe-Jauffret E, et al. ALDHI is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 2007;1:555-567.
13. Yun K, Tennent B. Cancer stem cells. Drug Discov Today 2008;4:47-51.
14. Kakarala M, Wicha MS. Implications of the cancer stem-cell hypothesis for breast cancer prevention and treatment. J Clin Oncol 2008;26: 2813-2820.
15. Fillmore CM, Kuperwasser C. Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy. Br Cancer Res 2008;10:1-13.
16. Hwang-Verslues WW, Chang KJ, Lee EY, Lee WH. Breast cancer stem cells and tumor suppressor genes. J Formos Med Assoc 2008;107: 751-766.
17. O'Brien CS, Howell SJ, Farnie G, Clarke RB. Resistance to endocrine therapy: are breast cancer stem cells the culprits? J Mammary Gland Biol Neoplasia 2009;14:45-54.
18. Muehlberg FL, Song YH, Krohn A, et al. Tissue-resident stem cells promote breast cancer growth and metastasis. Carcinogenesis 2009;30:589-597.
19. Charafe-Jauffret E, Ginestier C, Iovino F, et al. Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a dis-tinct molecular signal. Cancer Res 2009;69:1302-1313.
20. Tanei T, Morimoto K, Shimazu K, et al. Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resi-stance to sequential paclitaxel and epirubicin-based chemotherapy. Clin Cancer Res 2009;15:4234-4241.
21. Kenney NJ, Smith GH, Lawrence E, et al. Identification of stem cell units in the terminal end bud and duct of the mouse mammary gland. J Biomed Biotechnol 2001;1:133-143.
22. Smith GH. Label-retaining epithelial cells in mouse mammary gland divide asymmetrically and retain their template DNA strands. Develop-ment 2005;132:681-687.
23. Villadsen R. In search of a stem cell hierarchy in the human breast and its relevance to breast cancer evolution. APMIS 2005; 113:903-921.
24. DeOme KB, Faulkin LJ Jr, Bern HA, Blair PB. Development of mice mammary tumors from hyperplastic alveolar nodules transplanted into gland-free fat pads of female C3H mice. Cancer Res 1959;19: 515-520.
25. Tsai YC, Lu Y, Nichols PW, Zlotnikov G, Jones PA, Smith HS. Contiguous patches of normal mammary epithelium derive from a single stem cell: implications for breast carcinogenesis. Cancer Res 1996;56: 402-404.
26. Shackleton M, Vaillant F, Simpson KJ, et al. Generation of a functional mammary gland from a single stem cell. Nature 2006;439: 84-88.
27. Bissel MJ, LaBarge MA. Context, tissue plasticity, and cancer: are tumor stem cells also regulated by the microenvironment? Cancer Cell 2005;7:17-23.
28. Bhowmick NA, Chytil A, Plieth D, et al. TGF-A signalling in fibroblasts modulate the oncogenic potential of adjacent epithelia. Science 2004; 303:848-851.
29. Vona-Davis L, Rose DP. Angiogenesis, adipokines and breast cancer. Cytokine Growth Factor Rev 2009;20:193-201.
30. Siwko SK, Dong J, Lewis MT, et al. Evidence that an early pregnancy causes a persistent decrease in the number of functional mammary epithelial stem cellsVimplications for pregnancy-induced protection against breast cancer. Stem Cells 2008;26:3205-3209.
31. McBryan J, Howlin J, Napoletano S, Martin F. Amphiregulin: role in mammary gland development and breast cancer. J Mammary Gland Biol Neoplasia 2008;13:159-169.
32. Mueller SO, Clark JA, Myers PH, Korach KS. Mammary gland development in adult mice requires epithelial and stromal estrogen receptor α. Endocrinology 2002;143:2357-2365.
33. Mallepell S, Krust A, Chambon P, Brisken C. Paracrine signaling through the epithelial estrogen receptor α is required for proliferation and morphogenesis in the mammary gland. Proc Natl Acad Sci USA 2006;103:2196-2201.
34. Cunha GR, Young P, Hom YK, et al. Elucidation of a role for stromal steroid hormone receptors in mammary gland growth and development using tissue recombinants. J Mammary Gland Biol Neoplasia 1997;2: 393-402.
35. Russo J, Moral R, Balogh GA, Mailo D, Russo IH. Review: the pro-tective role of pregnancy in breast cancer. Breast Cancer Res 2005;7: 131-142.
36. Harvey JA, Santen RJ, Petroni GR, et al. Histological changes in the breast with menopausal hormone therapy use: correlation with breast density, estrogen receptor, progesterone receptor, and proliferation indices. Menopause 2008;15:67-73.
37. Clarke RB. Ovarian steroids and the human breast: regulation of stem cells and cell proliferation. Maturitas 2006;54:327-333.
38. Clarke RB. Human breast cell proliferation and its relationship to steroid receptor expression. Climacteric 2004;7:129-137.
39. Clarke RB, Spence K, Anderson E, et al. A putative human breast stem cell population is enriched for steroid receptor-positive cells. Dev Biol 2005;277:443-456.
40. Mousa NA, Casper RF. Menopausal estrogen deprivation activates steroid sensitive stem cells (3SC) and local estrogen biosynthesis: a model for breast cancer development. Biosci Hypotheses 2009;2: 252-256.
41. Anderson GL, Limacher M. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. J Am Med Assoc 2004;291: 1701-1712.
42. Sorlie T, Tibshirani R, Parker J, et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA 2003;100:8418-8423.
43. Hu X, Stern HM, Ge L, et al. Genetic alterations and oncogenic path-ways associated with breast cancer subtypes. Mol Cancer Res 2009;7: 511-522.
44. Sorlie T, Perou CM, Tibshirani R, et al. Gene expression patterns of breast carcinomas distinguishing tumor subclasses with clinical impli-cations. Proc Natl Acad Sci USA 2001;98:10869-10874.
45. Kapp AV, Jeffrey SS, Langerod A, et al. Discovery and validation of breast cancer subtypes. BMC Genomics 2006:7:231.
46. Cheung AM, Wan TS, Leung JC, et al. Aldehyde dehydrogenase acti-vity in leukemic blasts defines a subgroup of acute myeloid leukemia with adverse prognosis and superior NOD/SCID engrafting potential. Leukemia 2007;21:1423-1430.
47. Corti S, Locatelli F, Papadimitriou D, et al. Identification of a primitive brain-derived neural stem cell population based on aldehyde dehydro-genase activity. Stem Cells 2006;24:975-985.
48. Abraham BK, Fritz P, McClellan M, et al. Prevalence of CD44 AQ16 j/CD24j/low cells in breast cancer may not be associated with clinical outcome but may favor distant metastasis. Clin Cancer Res 2005;11: 1154-1159.
49. Trichopoulos D, Lagiou P, Adami HO. Towards an integrated model for breast cancer etiology. The crucial role of the number of mammary tissue-specific stem cells. Breast Cancer Res 2005;7:13-17.
50. Weigelt B, Bissell MJ. Unraveling the microenvironmental influences AQ16 on the normal mammary gland and breast cancer. Semin Cancer Biol 2008;18:311-321.
51. Horwitz KB, Dye WW, Harrell JC, Kabos P, Sartorius CA. Rare steroid receptor-negative basal-like tumorigenic cells in luminal subtype human breast cancer xenografts. Proc Natl Acad Sci USA 2008;105: 5774-5779.
52. Horwitz KB, Sartorius CA. Progestins in hormone replacement therapies reactivate cancer stem cells in women with pre-existing breast cancers: a hypothesis. J Clin Endocrinol Metab 2008;93:3295-3298.
53. Horwitz KB. The year in basic science: update of estrogen plus progestin therapy for menopausal hormone replacement implicating stem cells in the increased breast cancer risk. Mol Endocrinol 2008;22:2743-2750.
54. Groshong SD, Owen GI, Grimison B, et al. Biphasic regulation of breast cancer cell growth by progesterone: role of cyclin-dependent kinase inhibitors, p21 and p27(Kip1). Mol Endocrinol 1997;11:1593-1607.
55. Sartorius CA, Harvell DME, Shen T, Horwitz KB. Progestins ini-tiate a luminal to myoepithelial switch in estrogen-dependent human breast tumors without altering growth. Cancer Res 2005; 65:9779-9788.
56. Eisen A, Trudeau M, Shelley W, et al. Aromatase inhibitors in adjuvant therapy for hormone receptor positive breast cancer: a systematic review. Cancer Treat Rev 2008;34:157-174.
57. Chen WY, Manson JE, Hankinson SE, et al. Unopposed estrogen therapy and the risk of breast cancer. Arch Intern Med 2006;166: 1027-1032.
58. Stefanick ML, Anderson GL, Margolis KL, et al. Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy. JAMA 2006; 295:1647-1657.
59. Licznerska BE, Wegman PP, Nordenskjold B, Wingren S. In situ levels of estrogen producing enzymes and its prognostic significance in postmenopausal breast cancer patients. Breast Cancer Res Treat 2008;112:15-23.
60. Pasqualini JR, Chetrite GS. Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer. J Steroid Biochem Mol Biol 2005;93:221-236.
61. Aka JA, Mazumdar M, Lin SX. Reductive 17A-hydroxysteroid dehydrogenases in the sulfatase pathway: critical in the cell proliferation of breast cancer. Mol Cell Endocrinol 2009;301:183-190.
62. Stute P, Gotte M, Kiesel L. Differential effect of hormone therapy on E1S-sulfatase activity in non-malignant and cancerous breast cells in vitro. Breast Cancer Res Treat 2008;108:363-374.
63. Suzuki T, Miki Y, Akahira J, et al. Aromatase in human breast carcinoma as a key regulator of intratumoral sex steroid concentrations. Endocr J 2008;55:455-463.
64. Wren BG. Do female sex hormones initiate breast cancer? A review of the evidence. Climacteric 2004;7:120-128.
65. Suzuki T, Miki Y, Nakamura Y, et al. Sex steroid-producing enzymes in human breast cancer. Endocr Relat Cancer 2005;12: 701-720. (Pubitemid 41815772)
66. Yamaguchi Y, Hayashi S. Estrogen-related cancer microenvironment of breast carcinoma. Endocr J 2009;56:1-7.
67. Le Goff P, Montano MM, Schodin DJ, Katzenellenbogen BS. Phosphorylation of the human estrogen receptor. Identification of hormone regulated sites and examination of their influence on tran-scriptional activity. J Biol Chem 1994;269:4458-4466.
68. Kato S, Endoh H, Masushige Y, et al. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 1995;270:1491-1494.
69. Hayashi S, Yamaguchi Y. Estrogen signalling and prediction of endocrine therapy. Cancer Chemother Pharmacol 2005;56:27-31.
70. Ritter ER, Perry A, Yu J, et al. Breast cancer cell-derived fibroblast growth factor 2 and vascular endothelial growth factor are chemo-attractants for bone marrow stromal stem cells. Ann Surg 2008;247: 310-314.
71. Neels JG, Thinnes T, Losutoff DJ. Angiogenesis in an in vivo model of adipose tissue development. FASEB J 2004;18:983-985.
72. Welch HG, Black WC. Using autopsy series to estimate the disease Breservoir[for ductal carcinoma in situ of the breast: how much more breast cancer can we find? Ann Intern Med 1997;127:1023-1028.
73. Dlugosz AA, Talpaz M. Following the hedgehog to new cancer therapies. N Engl J Med 2009;361:1202-1203.
74. Lui S, Dontu G, Mantle ID, et al. Hedgehog signalling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res 2006;66:6063-6071.
75. Marcato P, Dean CA, Giacomantonio CA, Lee PWK. Oncolytic reovirus effectively targets breast cancer stem cells. Mol Ther 2009;17:972-979.